Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
Sinolink: Domestic computing power chain is expected to usher in a golden age. We remain optimistic about the high prosperity of the computing power chain market.
China: China's warehousing index for April is 51%
Weight reduced by 22.5%! Roche's GLP-1 new drug approved for clinical use in China for the first time.
Sinolink: Domestic computing power chain is expected to usher in a golden age. We remain optimistic about the high prosperity of the computing power chain market.
China: China's warehousing index for April is 51%
Weight reduced by 22.5%! Roche's GLP-1 new drug approved for clinical use in China for the first time.
